Successful ruxolitinib rechallenge after fedratinib failure in a patient with overt myelofibrosis.

Pinczés, László Imre; Jóna, Ádám; Mezei, Gabriella; Kenyeres, Anna; Vekszler, Péter Pambó; Illés, Árpád; Simon, Zsófia

Pinczés, László Imre; Jóna, Ádám; Mezei, Gabriella; Kenyeres, Anna; Vekszler, Péter Pambó; Illés, Árpád; Simon, Zsófia.

Afiliação

Pinczés LI; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. pinczes.laszlo.imre@med.unideb.hu.
Jóna Á; Doctoral School of Clinical Medicine, University of Debrecen, Debrecen, Hungary. pinczes.laszlo.imre@med.unideb.hu.
Mezei G; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Kenyeres A; Doctoral School of Clinical Medicine, University of Debrecen, Debrecen, Hungary.
Vekszler PP; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Illés Á; Doctoral School of Clinical Medicine, University of Debrecen, Debrecen, Hungary.
Simon Z; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Ann Hematol ; 2024 Aug 02.

Article em En | MEDLINE | ID: mdl-39090340

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Ann Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Hungria

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google